These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 2120548)
81. Inhibitory action of troglitazone, an insulin-sensitizing agent, on the calcium current in cardiac ventricular cells of guinea pig. Katoh Y; Hashimoto S; Kimura J; Watanabe T Jpn J Pharmacol; 2000 Feb; 82(2):102-9. PubMed ID: 10877527 [TBL] [Abstract][Full Text] [Related]
82. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. Okuno A; Tamemoto H; Tobe K; Ueki K; Mori Y; Iwamoto K; Umesono K; Akanuma Y; Fujiwara T; Horikoshi H; Yazaki Y; Kadowaki T J Clin Invest; 1998 Mar; 101(6):1354-61. PubMed ID: 9502777 [TBL] [Abstract][Full Text] [Related]
83. Antidiabetic activity of white skinned sweet potato (Ipomoea batatas L.) in obese Zucker fatty rats. Kusano S; Abe H Biol Pharm Bull; 2000 Jan; 23(1):23-6. PubMed ID: 10706405 [TBL] [Abstract][Full Text] [Related]
84. Troglitazone inhibits mitogenic signaling by insulin in vascular smooth muscle cells. Goetze S; Kim S; Xi XP; Graf K; Yang DC; Fleck E; Meehan WP; Hsueh WA; Law RE J Cardiovasc Pharmacol; 2000 May; 35(5):749-57. PubMed ID: 10813377 [TBL] [Abstract][Full Text] [Related]
85. Inhibition of KATP channel activity by troglitazone in CRI-G1 insulin-secreting cells. Lee K; Ibbotson T; Richardson PJ; Boden PR Eur J Pharmacol; 1996 Oct; 313(1-2):163-7. PubMed ID: 8905344 [TBL] [Abstract][Full Text] [Related]
86. Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism. Ishizuka T; Itaya S; Wada H; Ishizawa M; Kimura M; Kajita K; Kanoh Y; Miura A; Muto N; Yasuda K Diabetes; 1998 Sep; 47(9):1494-500. PubMed ID: 9726240 [TBL] [Abstract][Full Text] [Related]
87. Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides. Fukunaga Y; Itoh H; Doi K; Tanaka T; Yamashita J; Chun TH; Inoue M; Masatsugu K; Sawada N; Saito T; Hosoda K; Kook H; Ueda M; Nakao K Atherosclerosis; 2001 Sep; 158(1):113-9. PubMed ID: 11500181 [TBL] [Abstract][Full Text] [Related]
88. Effects of berberine on glucose metabolism in vitro. Yin J; Hu R; Chen M; Tang J; Li F; Yang Y; Chen J Metabolism; 2002 Nov; 51(11):1439-43. PubMed ID: 12404195 [TBL] [Abstract][Full Text] [Related]
89. Ciglitazone, a new hypoglycaemic agent. 3. Effect on glucose disposal and gluconeogenesis in vivo in C57BL/6J-ob/ob and -+/? mice. Chang AY; Gilchrist BJ; Wyse BM Diabetologia; 1983 Dec; 25(6):514-20. PubMed ID: 6662280 [TBL] [Abstract][Full Text] [Related]
90. Pioglitazone-induced alterations of purine metabolism in healthy male subjects. Kang J; Li Y; Lee S; Yu KS; Cho JY Clin Transl Sci; 2024 May; 17(5):e13834. PubMed ID: 38771175 [TBL] [Abstract][Full Text] [Related]